LSE · VLG.L
Venture Life Group plc
£0.68+£0.02 (+2.26%)
Venture Life Group plc’s quoted price sits in the upper half of its reported 52-week range, 5.56% below the high.
Loading market information…
LSE · SPEC.L · GBp
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · GBp. Historical prices are not a forecast.
INSPECS Group plc’s quoted price sits in the upper half of its reported 52-week range, 14.29% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
INSPECS Group plc’s next earnings report is currently expected on Jun 11, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow INSPECS Group plc’s reporting calendar.
THE COMPANY BEHIND THE TICKER
INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia. It operates through Frames and Optics; Manufacturing; and Lenses segments. The company offers its products under the retail brands, such as Barbour, Barbour International, BUFFALO David Bitton, CAT, Free Country, Henri Lloyd, Hype, JOSEPH, Lamb, Liberty, Lyle & Scott, Marc O’Polo, MINI, O’Neill, SUPERDRY, RADLEY LONDON, TALBOT RUNHOF, Ted Baker, Temperley LONDON, and Victor Rolf; and in house brands under BOTANIQ, SAVILE ROW Titanium, SAVILE ROW, BRENDEL Eyewear, FREIGEIST, HUMPHREY’S eyewear, JOS ESCHENBACH, and TITANFLEX names. INSPECS Group plc was founded in 1988 and is based in Bath, the United Kingdom.
Latest available per-share figures in GBP. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:41 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2023 | Apr 27, 2023 | -£0.05 | £115.36M |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
£0.68+£0.02 (+2.26%)
Venture Life Group plc’s quoted price sits in the upper half of its reported 52-week range, 5.56% below the high.
£1.90£0.00 (0.0%)
Kooth plc’s quoted price sits in the upper half of its reported 52-week range, 6.65% below the high.
£0.96£0.00 (0.0%)
ECO Animal Health Group plc’s quoted price sits in the lower half of its reported 52-week range, 18.31% below the high.
£0.06+£0.00 (+0.92%)
Shield Therapeutics plc’s quoted price sits in the lower half of its reported 52-week range, 56.0% below the high.
£0.10+£0.00 (+2.63%)
Ondine Biomedical Inc.’s quoted price sits in the upper half of its reported 52-week range, 37.1% below the high.
£0.11+£0.00 (+1.11%)
Creo Medical Limited’s quoted price sits in the lower half of its reported 52-week range, 38.51% below the high.
£6.80+£0.07 (+1.04%)
Hemogenyx Pharmaceuticals Plc’s quoted price sits in the lower half of its reported 52-week range, 44.26% below the high.
₪0.46-₪0.01 (-1.72%)
BATM Advanced Communications Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.27% below the high.
